On Aug 26, 2021 Eclipse Regenesis closed a Grant round and raised $1,700,000 from National Institutes of Health, featuring lead investors National Institutes of Health.

About the company: Eclipse Regenesis is located at United States, North America.
“Eclipse Regenesis is the first tissue regeneration therapy for Short Bowel Syndrome (SBS). Click to learn more.”

Company website: http://www.eclipseregenesis.com